Global Health Corporate Filings & Announcements

Healthcare Facilities company Global Health announced Q2FY26 results Consolidated Total Income of Rs 11,189 million, compared to Rs 9,748 million in Q2FY25; reflecting a growth of 14.8 % YoY. EBITDA1 (ex-Noida3 ) grew 13.7 % YoY to Rs 2,804 with margins of 25.2% compared to 25.3% in Q2FY25. Including Noida, EBITDA was Rs 2,607 million, up 5.7% YoY, with margins at 23.3%. Medanta Noida commenced operations in September 2025. The hospital generated Revenue of Rs 39 million and EBITDA loss of Rs 197 million. Profit After Tax was Rs 1,584 million, growth of 21.1% YoY. PAT margins improved to 14.2% from 13.4% in Q2FY25. During the quarter, 37 new beds were added at Patna, taking total bed addition to 57 beds in H1FY26 in Patna. Occupied bed days increased by 7.7% YoY, representing an occupancy of ~64% on increased bed capacity. ARPOB grew by 5.5% YoY to Rs 65,570 in Q2FY26, driven by increase in realization and change in speciality mix. Volume growth remained robust, In-patient count increased by 12.7% and Out-patient count increased by 14.9% YoY. Matured hospitals revenue was Rs 7,200 million, growth of 5.4% YoY. EBITDA was Rs 1,696 million, growth of 0.4% YoY. Developing hospitals ex Noida, Revenue was Rs 3,531 million, growth of 28.3% YoY. EBITDA increased 34.0% YoY to Rs 1,112 million, with margins improving to 31.5% compared to 30.1% in Q2FY25. Including Noida, EBITDA stood at Rs 915 million, with margin of 25.6%, reflecting the impact of initial ramp-up costs. International Patients Revenue increased by 48.5% YoY to Rs 762 million in Q2FY26, driven by increased international patient volume. OPD Pharmacy (Hospital & Retail) continues to register strong double digit growth. Revenue increased by 23.9% YoY to Rs 456 million in Q2FY26. Pankaj Sahni, Group CEO & Director, said: “We are extremely pleased to share that in September 2025, we launched our sixth hospital, a stateof-the-art, 550-bed facility in Noida. Over 150 doctors across key specialties have already joined the hospital, supported by the deployment of advanced medical technologies, they will be able to deliver world-class care in the region. We are encouraged by the initial response from the community and are progressively ramping up operations. During the quarter, the Company delivered a strong performance, with Revenue Growth of 15% year-on-year and 6% sequential growth. EBITDA (excluding Noida) grew 14% year-on-year and 10% sequentially. Growth momentum remained broad-based across our network." Result PDF

Global Health Corporate Filings & Announcements

Latest corporate announcements and filings from Global Health on BSE